Acrivon Therapeutics Inc

ACRVNASDAQ
$1.96
-0.04-2%
At close: Sep 14, 5:00 PM EST
$1.98
0.01540.79%
After Hours: 4:33 PM EST

Acrivon Therapeutics Ownership & Insider Activity

Acrivon Therapeutics (ACRV) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 7.7% of shares outstanding. Institutional investors hold 6.5%. Over the past 90 days, insiders made 8 sales worth $40K.

Shares Outstanding

42.853M

Shares Float

28.711M

Insider Shares Owned

3.305M

Insider % Owned

7.7%

Institutional Shares Held

2.765M

Institutional % Held

6.5%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

0

Sales (90d)

8

$40K total

Net Activity

Net Selling

Net Value (90d)

-$40K

Acrivon Therapeutics Insider Transactions (Last 6 Months)

See all insider trades
DateInsiderTitleTypeSharesPriceValue
Aug 25, 2026Peter BlumeJensen, Kristina MassonPRESIDENT AND CEO, EVP - BUSINESS OPERATIONSSELL14.036K$2.21$31K
Aug 18, 2026Katharine PetersonCHIEF ACCOUNTING OFFICERSELL101.000$2.01$203